Evidence map›Paper›PMID 34693965›Full record

ArticleFaraday discussions2021

Spiers Memorial Lecture: Analysis and

Huong T Kratochvil, Robert W Newberry, Bruk Mensa, Marco Mravic, William F DeGrado

Abstract read
In one paragraph

Article in Faraday discussions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Design principles of the common Gly-X6-Gly membrane protein building block.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. α-Synuclein and biological membranes: the danger of loving too much.Chemical communications (Cambridge, England) · 2023
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huong T KratochvilDepartment of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, CA 94158, USA. william.degrado@ucsf.edu.ORCID 0000-0001-8039-6823
Robert W NewberryDepartment of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, CA 94158, USA. william.degrado@ucsf.edu.ORCID 0000-0002-2020-2641
Bruk MensaDepartment of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, CA 94158, USA. william.degrado@ucsf.edu.ORCID 0000-0002-8777-5946
Marco MravicDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0001-6294-1824
William F DeGradoDepartment of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, CA 94158, USA. william.degrado@ucsf.edu.ORCID 0000-0003-4745-263X

Funding

STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008284 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 1988 to 2022
$10.1M
Deciphering the relationship between structure, dynamics and function in helical bundle proteinsR35GM122603 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILLIAM DEGRADO · 2017 to 2026
$7.1M
A 600 MHz NMR console and cryoprobe for studies of macromolecules, drug discovery and cancer biomarkersS10OD023455 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, JOHN D · 2018 to 2018
$820k
Biophysical Determinants of Physiological and Pathological alpha-Synuclein Membrane InteractionsK99NS116679 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NEWBERRY, ROBERT WILLIAM · 2021 to 2022
$200k
Proton Conduction Pathways in Proton Channel ProteinsK99GM138753 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRATOCHVIL, HUONG TRAN · 2020 to 2021
$194k
NIGMS NIH HHS K99 GM138753NIGMS NIH HHS R35 GM122603NIGMS NIH HHS T32 GM008284NIH HHS S10 OD023455NINDS NIH HHS K99 NS116679
6 · The paper itself

Abstract

Membrane-peptide interactions play critical roles in many cellular and organismic functions, including protection from infection, remodeling of membranes, signaling, and ion transport. Peptides interact with membranes in a variety of ways: some associate with membrane surfaces in either intrinsically disordered conformations or well-defined secondary structures. Peptides with sufficient hydrophobicity can also insert vertically as transmembrane monomers, and many associate further into membrane-spanning helical bundles. Indeed, some peptides progress through each of these stages in the process of forming oligomeric bundles. In each case, the structure of the peptide and the membrane represent a delicate balance between peptide-membrane and peptide-peptide interactions. We will review this literature from the perspective of several biologically important systems, including antimicrobial peptides and their mimics, α-synuclein, receptor tyrosine kinases, and ion channels. We also discuss the use of

Indexed as

PeptidesHydrophobic and Hydrophilic InteractionsProtein Structure, SecondaryPeptides

Identifiers

PMID34693965
PMCPMC8979563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.